After immunization with the AstraZeneca vaccine, a man developed an abnormal blood clot with low platelet levels
Health department Canadian It was reported on Tuesday that they are investigating the country’s first possible case. thrombus versus vaccine AstraZeneca, At the same time, they said they have asked Johnson & Johnson to provide more information about the appearance of its vaccine-related clots.
Health Canada said on Twitter today that it has received “a post-immunization report from someone in Canada stating that the person has an abnormal blood clot and low platelet content. Windshield, AstraZeneca vaccine produced by the Serum Institute of India. ”
This is a woman living in Quebec and her age is unknown. The Quebec government explained that the patient is recovering at home.
The health authorities added that this is the first reported case in the country, and they continue to “cooperate with international regulatory agencies to obtain available data and evidence.”
However, the Ministry of Health did not order a suspension of vaccine use and emphasized: “These reports are very unusual and show that Canada’s vaccine safety control system is effective.”
In late March, the National Advisory Committee on Immunization of Canada (NACI) recommended to stop using AstraZeneca vaccine Due to the adverse reaction information from Europe, the health status of people under 55 years old has deteriorated.
Canada is receiving two versions of the vaccine. One is produced by the Anglo-Swedish company AstraZeneca, and the other is produced by the Serum Institute of India.
Last month, Canadian authorities tried to ensure the safety of the country’s population and distinguished between the two vaccines, noting that although the one produced in India is biologically the same as the AstraZeneca vaccine, it is under different conditions. produced.
To date, Canada has administered more than 700,000 doses vaccine The country received 2 million doses of AstraZeneca.
About the decision United States After suspending the use of Johnson & Johnson’s Johnson vaccine, Canadian authorities stated that although the product was approved for use in Canada on March 5, “it has not yet arrived in Canada.